MELANIE HUG: Open Payments
NPI 1598291734 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 17 payments from 7 companies in 2025. Trend: 2023 $41 · 2024 $0 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $227 |
| Gilead Sciences, Inc. | 1 | $124 |
| Indivior Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: CAPLYTA, SUBLOCADE, ABILIFY MAINTENA, UZEDY, COBENFY, VRAYLAR, REXULTI.
Industry payments across OH — which companies pay providers there.
